Invitae Investor Relations Material
Latest events
Q3 2023
Invitae
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Invitae Corporation
Access all reports
Segment Data
Access more data
Revenue by
Source
Test revenue
Other
Expenses by
Financials
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people. The company offers clinical and genetic testing services to evaluate the risk of inherited conditions. It also provides diagnostic products and services, including laboratory developed tests and other diagnostic reagents to physicians and hospitals. The company offers hereditary cancer testing services under the Vectra 360 brand, prenatal testing services under the Angelica brand, and germline gene mutation screening under the Genomind brand. The company is based in San Francisco, California.
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
NVTA
Country
🇺🇸 United States